Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Milosevic

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Blood|August 20, 2020
Germline genetic factors influence the outcome of interferon-α therapy in polycythemia veraRoland Jäger, Heinz Gisslinger, Elisabeth Fuchs, et al.
Annals of Hematology|July 24, 2015
Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion geneElisa Rumi, Jelena D Milosevic, Dominik Selleslag, et al.
International Journal of Molecular Sciences|February 15, 2019
Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AMLPeter Valent, Wolfgang Kern, Gregor Hoermann, et al.
Medicina (Kaunas, Lithuania)|February 25, 2022
Impact of Sensorineural Hearing Loss during the Pandemic of COVID-19 on the Appearance of Depressive Symptoms, Anxiety and StressEmilija M Zivkovic Marinkov, Natasa K Rancic, Dusan R Milisavljevic, et al.
Blood|May 25, 2016
LNK mutations in familial myeloproliferative neoplasmsElisa Rumi, Ashot S Harutyunyan, Daniela Pietra, et al.
The Journal of Experimental Medicine|July 13, 2016
Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosisTakafumi Shimizu, Lucia Kubovcakova, Ronny Nienhold, et al.
American Journal of Hematology|January 11, 2022
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasmsJelena D Milosevic Feenstra, Roland Jäger, Fiorella Schischlik, et al.
Blood|February 21, 2014
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosisElisa Rumi, Ashot S Harutyunyan, Daniela Pietra, et al.
Blood|January 13, 2019
CDK6 coordinates <i>JAK2</i> <sup><i>V617F</i></sup> mutant MPN via NF-κB and apoptotic networksIris Z Uras, Barbara Maurer, Harini Nivarthi, et al.
Blood|October 2, 2015
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasmsJelena D Milosevic Feenstra, Harini Nivarthi, Heinz Gisslinger, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Blood|August 20, 2020
Germline genetic factors influence the outcome of interferon-α therapy in polycythemia veraRoland Jäger, Heinz Gisslinger, Elisabeth Fuchs, et al.
Annals of Hematology|July 24, 2015
Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion geneElisa Rumi, Jelena D Milosevic, Dominik Selleslag, et al.
International Journal of Molecular Sciences|February 15, 2019
Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AMLPeter Valent, Wolfgang Kern, Gregor Hoermann, et al.
Medicina (Kaunas, Lithuania)|February 25, 2022
Impact of Sensorineural Hearing Loss during the Pandemic of COVID-19 on the Appearance of Depressive Symptoms, Anxiety and StressEmilija M Zivkovic Marinkov, Natasa K Rancic, Dusan R Milisavljevic, et al.
Blood|May 25, 2016
LNK mutations in familial myeloproliferative neoplasmsElisa Rumi, Ashot S Harutyunyan, Daniela Pietra, et al.
The Journal of Experimental Medicine|July 13, 2016
Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosisTakafumi Shimizu, Lucia Kubovcakova, Ronny Nienhold, et al.
American Journal of Hematology|January 11, 2022
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasmsJelena D Milosevic Feenstra, Roland Jäger, Fiorella Schischlik, et al.
Blood|February 21, 2014
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosisElisa Rumi, Ashot S Harutyunyan, Daniela Pietra, et al.
Blood|January 13, 2019
CDK6 coordinates <i>JAK2</i> <sup><i>V617F</i></sup> mutant MPN via NF-κB and apoptotic networksIris Z Uras, Barbara Maurer, Harini Nivarthi, et al.
Blood|October 2, 2015
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasmsJelena D Milosevic Feenstra, Harini Nivarthi, Heinz Gisslinger, et al.
Pageof 6